K2 HealthVentures

#ICYMI - Check out CEO & Founding Managing Director, Parag Shah's interview with Jon Chee from the Biotech Startups Podcast to learn more about creating innovative financing solutions for emerging biotech companies who have very specific needs.

"Think what your real intentions are, and then don't be scared to put them out there. And then, you know, as a good friend of mine told me in grad school, ‘really touch base with what your intentions are.’ The universe will ultimately conspire to help you, but you have to be clear about what it is." In Part 2 of The Biotech Startups Podcast our CEO & Founding Managing Director, Parag Shah and Jon Chee explore the power of clarity in intentions and how it can shape one's career trajectory. Learn how this philosophy contributed to the formation of K2HV and its dual commitment of "profit with a purpose."

Interested in learning more about how K2 HealthVentures creates innovative financing solutions for emerging biotech companies? Check out CEO & Founding Managing Director, Parag Shah's interview with Jon Chee from the Biotech Startups Podcast to discover how debt financing works and hear about Parag's career at the intersection of science, finance, and entrepreneurship.

Congrats to Umoja Biopharma on their $100 Million Series C. This financing will help advance their pipeline of?in vivo CAR T cell generating therapies, which have the potential to increase effectiveness, reduce barriers, and expand access to CAR T cell therapies.

Chronic kidney disease places a significant burden on the U.S. healthcare system and, more importantly, the lives of patients. We are?proud to support?Evergreen Nephrology, a leader in value-based kidney care, alongside?Rubicon Founders, Oak HC/FT, and other investors. This funding will fuel the company's growth by enabling its expansion into new regions and broadening the tools and resources they make available for their physician?partners?to improve clinical outcomes and streamline patient-centered care delivery.

Did you know that a recent survey shows that roughly a third of Medicare patients (both Traditional and Medicare Advantage) struggle to access primary care? We are proud to support HarmonyCares, a leading provider of value-based, in-home longitudinal care. This capital raise will help expand their footprint and develop new technology to drive clinical outcomes and patient satisfaction at scale.

This week Life Science Cares Boston launched a Health Equity Portfolio Co-Investment Program as part of its Anti-Poverty Strategy for Greater Boston. We are proud that our foundation is able to support LSC’s new grantmaking program aimed at addressing health inequities among low-income families and communities in the area. Learn more: https://bit.ly/4aMDXnJ #lifesciences #giveback #antipoverty

Earlier this week K2HV attended Life Science Cares Boston’s Impact Breakfast & was awarded the Luke Timmerman Impact Award. Our team is honored to have received this recognition. In Parag Shah’s words, “We are up here?being recognized?because we notice the inequities that are out there, and we are fortunate to be able to give from our abundance, to give a little bit back.” As an anchor investor in Life Science Cares’ new Health Equity?initiative, we are grateful to all those joining in our efforts to improve health equity & thank you Luke Timmerman for the honor.?